🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆
Clinical Trials in Denmark / NCT07476638
Recruiting Not applicable

Impact of AI Feedback on Ultrasound Biometry Accuracy Across the Expertise Levels

NCT07476638 · tracked via the Priya Life Science Denmark tracker
Phase
Not applicable
Started
2026-03-01
Last updated
2026-08-06

Condition(s) studied

Fetal Growth AbnormalitiesFetal Weight

Investigational drug(s) / intervention(s)

AI interventional group

AI interventional group: Participants in the intervention arm perform fetal biometry with the assistance of real-time Artificial Intelligence (AI) feedback software.

Study summary

Objective: To evaluate the impact of real-time AI feedback on fetal biometry accuracy and investigate the Expertise Reversal Effect-whether AI benefits diminish as user experience increases.

Design: A stratified randomized trial of 75 participants (25 Novices, 25 Intermediates, 25 Experts). Users are randomized 1:1 to either AI-assisted or manual measurement groups.

Outcomes:

* Primary: EFW accuracy (MAPE) compared to actual birthweight.
* Secondary: Procedure time, image quality, error relative to baseline scans, and cognitive workload (NASA-TLX).

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Clinical Target Population: Healthcare professionals and students, including but not limited to: * Medical students (doing their masters. * Resident physicians and Senior Consultants in Obstetrics and Gynecology. Exclusion: \- If the participants do not understand and speak either Danish or English Pregnant women: Inclusion Criteria: * Pre pregnancy BMI \< 40 * Singelton pregnancy * GA ≥ 37+0 at time of induction * Intact membranes (to ensure consistent amniotic fluid index) Exclusion Criteria: * Major fetal anatomical anomaly * Anhydramnios (DVP \< 2 cm) * CPR ratio \< 2.5th percentile

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
Nordsjællands Hospital Hillerød Capital Region Not Yet Recruiting
Rigshospitalet Copenhagen København Ø Enrolling By Invitation
Rigshospitalet Copenhagen København Ø Recruiting

More Copenhagen Academy for Medical Education and Simulation trials in Denmark

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07476638 on ClinicalTrials.gov ↗ ← All trials in Denmark